Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti NDA

drugsApril 03, 2019

Tag: gastroparesis , Evoke Pharma , Gimoti

PharmaSources Customer Service